Jump to content

Gene Editing Patent Application Trends 2025: Difference between revisions

From WikiPatents
← Older editNewer edit →
Updating Gene Editing Patent Application Trends 2025
Updating Gene Editing Patent Application Trends 2025
Line 1: Line 1:
== Gene Editing Patent Application Filing Activity ==
== Gene Editing Patent Application Filing Activity ==
== Gene Editing patent applications in 2025 ==
== Gene Editing patent applications in 2025 ==
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_March 2025.png|border|800px]]


== Top Technology Areas in Gene Editing ==
== Top Technology Areas in Gene Editing ==
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_March 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
** Count: 91 patents
** Count: 117 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
** Count: 84 patents
** Count: 108 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
** Count: 48 patents
** Count: 60 patents
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
** Count: 47 patents
** Count: 55 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
** Count: 41 patents
** Count: 49 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
** Count: 35 patents
** Count: 44 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
** Count: 33 patents
** Count: 40 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
** Count: 19 patents
** Count: 22 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
** Count: 19 patents
** Count: 22 patents
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
** Count: 15 patents
** Count: 21 patents
** Example: [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]]
** Example: [[20250034562. COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES (ASTRAZENECA AB)]]


== Top Companies in Gene Editing 2025 ==
== Top Companies in Gene Editing 2025 ==
Line 42: Line 42:


=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Gene Editing patents: 7
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 4 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 4 patents
** [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available): 2 patents
* Recent patents:
** [[20250092391. PROMOTERS FOR VIRAL-BASED GENE THERAPY (The Regents of the University of California)]] (20250320)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
** [[20250101385. GENE EDITING TO IMPROVE PANCREATIC BETA CELL YIELD IN DIRECTED DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS (The Regents of the University of California)]] (20250327)
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
* Number of Gene Editing patents: 5
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 5 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
* Recent patents:
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250101468. DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY (The Broad Institute, Inc.)]] (20250327)
** [[20250101500. AMPLIFICATION ASSAYS USING CRISPR-CAS BASED DETECTION (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C07K16/2809|C07K16/2809]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_A61K39/3955|A61K39/3955]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
* Recent patents:
* Recent patents:
** [[20250000945. Suppression of Neurodegeneration with Zinc Transporter Protein 7 (The Regents of the University of California)]] (20250102)
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
** [[20250075175. EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS (The Regents of the University of California)]] (20250306)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
** [[20250099623. COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION (THE BROAD INSTITUTE, INC.)]] (20250327)
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 4
Line 71: Line 91:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
=== [[:Category:The Trustees of Columbia University in the City of New York|The Trustees of Columbia University in the City of New York]] ===
* Number of Gene Editing patents: 3
* Top CPC codes:
** [[:Category:CPC_C12Q1/6869|C12Q1/6869]] (No explanation available): 1 patents
** [[:Category:CPC_C07H19/10|C07H19/10]] (No explanation available): 1 patents
** [[:Category:CPC_C07H21/00|C07H21/00]] (No explanation available): 1 patents
* Recent patents:
** [[20250066848. DNA SEQUENCING BY SYNTHESIS USING MODIFIED NUCLEOTIDES AND NANOPORE DETECTION (The Trustees of Columbia University in the City of New York)]] (20250227)
** [[20250075234. COMPOSITIONS AND METHODS FOR BASE EDITING KINASE GENES (The Trustees of Columbia University in the City of New York)]] (20250306)
** [[20250098652. Genetic Modifications for Xenotransplantation (The Trustees of Columbia University in the City of New York)]] (20250327)
=== [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
* Recent patents:
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250099556. METHODS OF AND COMPOSITIONS FOR REDUCING GENE EXPRESSION AND/OR ACTIVITY (Christiana Care Gene Editing Institute, Inc.)]] (20250327)
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 111: Line 141:
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]] ===
* Number of Gene Editing patents: 2
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
** [[20250002946. Methods And Compositions For Increasing Homology-Directed Repair (Regeneron Pharmaceuticals, Inc.)]] (20250102)
=== [[:Category:Monsanto Technology LLC|Monsanto Technology LLC]] ===
* Number of Gene Editing patents: 2
* Top CPC codes:
** [[:Category:CPC_C12N15/8213|C12N15/8213]] (No explanation available): 2 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 1 patents
* Recent patents:
** [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]] (20250130)
** [[20250027098. METHOD FOR SELECTING TARGET SITES FOR SITE-SPECIFIC GENOME MODIFICATION IN PLANTS (Monsanto Technology LLC)]] (20250123)
=== [[:Category:Caribou Biosciences, Inc.|Caribou Biosciences, Inc.]] ===
* Number of Gene Editing patents: 2
* Top CPC codes:
** [[:Category:CPC_C12Q1/6855|C12Q1/6855]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 1 patents
** [[:Category:CPC_C07K16/2878|C07K16/2878]] (No explanation available): 1 patents
* Recent patents:
** [[20250034633. A METHOD OF CAPTURING CRISPR ENDONUCLEASE CLEAVAGE PRODUCTS (Caribou Biosciences, Inc.)]] (20250130)
** [[20250027078. DNA-CONTAINING POLYNUCLEOTIDES AND GUIDES FOR CRISPR TYPE V SYSTEMS, AND METHODS OF MAKING AND USING THE SAME (Caribou Biosciences, Inc.)]] (20250123)


== New Companies in Gene Editing (Last Month) ==
== New Companies in Gene Editing (Last Month) ==
Line 147: Line 150:
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]


* [[:Category:CPC_G06T2207/20212|G06T2207/20212]] (No explanation available)
* [[:Category:CPC_C12Q2600/112|C12Q2600/112]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101528. USES OF CELL-FREE DNA FRAGMENTATION PATTERNS ASSOCIATED WITH EPIGENETIC MODIFICATIONS (Centre for Novostics)]]
* [[:Category:CPC_G06T2207/10024|G06T2207/10024]] (No explanation available)
* [[:Category:CPC_C12Y302/0101|C12Y302/0101]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H04N23/16|H04N23/16]] (No explanation available)
* [[:Category:CPC_C12Y301/03024|C12Y301/03024]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T7/80|G06T7/80]] (No explanation available)
* [[:Category:CPC_C12Y301/0301|C12Y301/0301]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T5/80|G06T5/80]] (No explanation available)
* [[:Category:CPC_C12Y301/03009|C12Y301/03009]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T5/50|G06T5/50]] (No explanation available)
* [[:Category:CPC_C12Y207/07027|C12Y207/07027]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G02B27/141|G02B27/141]] (No explanation available)
* [[:Category:CPC_C12Y207/07009|C12Y207/07009]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H04N9/646|H04N9/646]] (No explanation available)
* [[:Category:CPC_C12Y207/01002|C12Y207/01002]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_B82Y30/00|B82Y30/00]] (No explanation available)
* [[:Category:CPC_C12Y207/01001|C12Y207/01001]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250015474. METALENS (FUJIFILM Corporation)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H01P3/20|H01P3/20]] (No explanation available)
* [[:Category:CPC_C12Y204/01014|C12Y204/01014]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250015474. METALENS (FUJIFILM Corporation)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]


== Top Companies in Emerging Gene Editing Technologies 2025==
== Top Companies in Emerging Gene Editing Technologies 2025==
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]


* [[:Category:Meta Platforms Technologies, LLC|Meta Platforms Technologies, LLC]]: 8 patents
* [[:Category:SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY|SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY]]: 9 patents
* [[:Category:FUJIFILM Corporation|FUJIFILM Corporation]]: 2 patents
* [[:Category:Centre for Novostics|Centre for Novostics]]: 1 patents


== Top Inventors in Gene Editing ==
== Top Inventors in Gene Editing ==
Line 211: Line 214:
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 2 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Tedd D. Elich|Tedd D. Elich of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Jonathan Gootenberg|Jonathan Gootenberg of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 1 patents
** [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]]: 1 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 2 patents
** [[:Category:President and Fellows of Harvard College|President and Fellows of Harvard College]]: 1 patents
* Recent patents:
** [[20250090687. MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA (The Broad Institute, Inc.)]] (20250320)
** [[20250092374. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College)]] (20250320)
** [[20250011748. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (The Broad Institute, Inc.)]] (20250109)
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 243: Line 292:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
=== [[:Category:Tyson D. Bowen|Tyson D. Bowen of Morrisville NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
=== [[:Category:Mark Moore|Mark Moore of Durham NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Tedd D. Elich|Tedd D. Elich of Durham NC (US)]] ===
=== [[:Category:Michael Lassner|Michael Lassner of Portland OR (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Andrew Garst|Andrew Garst of Pleasanton CA (US)]] ===
=== [[:Category:Andrew Garst|Andrew Garst of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 407: Line 459:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Pravin Kumar R|Pravin Kumar R]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Gladstone Sigamani G|Gladstone Sigamani G]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Roopa L|Roopa L]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Edwin Neumann|Edwin Neumann of Somerville MA (US)]] ===
=== [[:Category:Edwin Neumann|Edwin Neumann of Somerville MA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 463: Line 539:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
=== [[:Category:Lior Izhar|Lior Izhar]] ===
=== [[:Category:Omar Abudayyeh|Omar Abudayyeh of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:Nadav Marbach Bar|Nadav Marbach Bar]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:Liat Rockah|Liat Rockah]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:Nurit Meron|Nurit Meron]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:Ophir Adiv Tal|Ophir Adiv Tal]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]]: 1 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:Ariel Gispan|Ariel Gispan]] ===
=== [[:Category:Cynthia Hao|Cynthia Hao of Saratoga CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)
=== [[:Category:Idit Buch|Idit Buch]] ===
=== [[:Category:Max R. Salick|Max R. Salick of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)
=== [[:Category:Abdoulaye Ndao|Abdoulaye Ndao of Brookline MA (US)]] ===
=== [[:Category:Ci Chu|Ci Chu of Palo Alto CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Imagia, Inc.|Imagia, Inc.]]: 2 patents
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
** [[20250052925. Frequency-Selective Optical Metalens Filters (Imagia, Inc.)]] (20250213)
** [[20250012944. Optical Metalens Systems and Methods of Manufacture (Imagia, Inc.)]] (20250109)
=== [[:Category:Dan Michael WEINTHAL|Dan Michael WEINTHAL]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
=== [[:Category:Yoel Moshe SHIBOLETH|Yoel Moshe SHIBOLETH]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
=== [[:Category:David STEINER|David STEINER]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
=== [[:Category:Talya KUNIK|Talya KUNIK]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)


== Top Collaborations in Gene Editing ==
== Top Collaborations in Gene Editing ==
Line 554: Line 579:
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]


* Cambridge: 35 inventors
* Cambridge: 56 inventors
* Shenzhen: 20 inventors
* San Francisco: 25 inventors
* Philadelphia: 19 inventors
* Shenzhen: 24 inventors
* Shanghai: 19 inventors
* Shanghai: 23 inventors
* San Francisco: 18 inventors
* Philadelphia: 20 inventors
* Pleasanton: 17 inventors
* Pleasanton: 17 inventors
* South Boston: 17 inventors
* South Boston: 17 inventors
* San Diego: 14 inventors
* San Diego: 14 inventors
* La Jolla: 14 inventors
* Seattle: 14 inventors
* New York: 13 inventors
* Beijing: 13 inventors
* Boston: 12 inventors
* Berkeley: 12 inventors
* Oakland: 12 inventors
* Suwon-si: 12 inventors
* Wuxi: 12 inventors
* Qingdao: 12 inventors
* Qingdao: 12 inventors
* New York: 11 inventors
* London: 11 inventors
* Berkeley: 11 inventors
* Oakland: 11 inventors
* Boston: 10 inventors
* Milano: 10 inventors
* Milano: 10 inventors
* Rehovot: 9 inventors
* St. Louis: 9 inventors
* London: 9 inventors
* Beijing: 8 inventors
* Worcester: 7 inventors
* Copenhagen: 7 inventors


[[Category:Gene Editing]]
[[Category:Gene Editing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Revision as of 08:05, 1 April 2025

Gene Editing Patent Application Filing Activity

Gene Editing patent applications in 2025

Error creating thumbnail: File missing

Top Technology Areas in Gene Editing

Error creating thumbnail: File missing

Top CPC Codes

Top Companies in Gene Editing 2025

The Regents of the University of California

The Broad Institute, Inc.

THE BROAD INSTITUTE, INC.

SHENZHEN METALENX TECHNOLOGY CO.,LTD

EmendoBio Inc.

The Trustees of Columbia University in the City of New York

Christiana Care Gene Editing Institute, Inc.

The Trustees of the University of Pennsylvania

CRISPR Therapeutics AG

PIONEER HI-BRED INTERNATIONAL, INC.

New Companies in Gene Editing (Last Month)

File:New Companies in Gene Editing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

Top Companies in Emerging Gene Editing Technologies 2025

Top Inventors in Gene Editing

Chenglong HAO

Fengze TAN

Jian ZHU

Feng Zhang of Cambridge MA (US)

Alexandra Briner Crawley of Cary NC (US)

Tedd D. Elich of Durham NC (US)

Jonathan Gootenberg of Cambridge MA (US)

David R. Liu of Cambridge MA (US)

Leida Rassouli-Taylor of Philadelphia PA (US)

Lior IZHAR

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Liat ROCKAH

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Nir HECHT

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Tyson D. Bowen of Morrisville NC (US)

Mark Moore of Durham NC (US)

Michael Lassner of Portland OR (US)

Andrew Garst of Pleasanton CA (US)

Ryan T. Gill of Pleasanton CA (US)

Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)

Eric B. Kmiec of Middletown DE (US)

Kelly H. Banas of Bear DE (US)

Joseph J. HIGGINS of Lexington MA (US)

Nancy CRAIG of Lexington MA (US)

Christopher BROWN of Albany CA (US)

Cindy CASTELLE of San Francisco CA (US)

Lisa ALEXANDER of Albany CA (US)

Yi-Shan Chen of South Boston MA (US)

Sandeep Soni of South Boston CA (US)

Laura Serwer of South Boston MA (US)

Jonathan Terrett of South Boston MA (US)

John Kulman of South Boston MA (US)

Benjamin OAKES of El Cerrito CA (US)

Sean HIGGINS of Alameda CA (US)

Sarah DENNY of San Francisco CA (US)

Brett T. STAAHL of Tiburon CA (US)

Isabel COLIN of Oakland CA (US)

Pravin Kumar R

Gladstone Sigamani G

Roopa L

Edwin Neumann of Somerville MA (US)

Tessa Bertozzi of Cambridge MA (US)

Jonathan Weissman of Cambridge MA (US)

Jesse Salk of Seattle WA (US)

Lawrence A. Loeb of Bellevue WA (US)

Michael Schmitt of Seattle WA (US)

ZHENGLIN HOU of ANKENY IA (US)

JOSHUA K. YOUNG of JOHNSTON IA (US)

Omar Abudayyeh of Cambridge MA (US)

Cynthia Hao of Saratoga CA (US)

Max R. Salick of San Francisco CA (US)

Ci Chu of Palo Alto CA (US)

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors


Top Cities for Gene Editing Inventors

  • Cambridge: 56 inventors
  • San Francisco: 25 inventors
  • Shenzhen: 24 inventors
  • Shanghai: 23 inventors
  • Philadelphia: 20 inventors
  • Pleasanton: 17 inventors
  • South Boston: 17 inventors
  • San Diego: 14 inventors
  • La Jolla: 14 inventors
  • Seattle: 14 inventors
  • New York: 13 inventors
  • Beijing: 13 inventors
  • Boston: 12 inventors
  • Berkeley: 12 inventors
  • Oakland: 12 inventors
  • Suwon-si: 12 inventors
  • Wuxi: 12 inventors
  • Qingdao: 12 inventors
  • London: 11 inventors
  • Milano: 10 inventors
Retrieved from "https://wikipatents.org/index.php?title=Gene_Editing_Patent_Application_Trends_2025&oldid=447941"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.